Skip to main content

Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology

Partnership to deliver a novel AI-native integrated CNS oncology platform Platform will unify and analyze Plus’ proprietary therapeutic, diagnostic, and bioinformatics datasets to accelerate precision neuro-oncology HOUSTON, May 19, 2026 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics for central nervous system (CNS) cancers, today announces that it has signed an agreement to enter into a strategic partnership with Ephemeral Technologies (“Ephemeral”) to deliver a unique AI execution platform for CNS oncology. The AI execution platform is designed to integrate, organize, and derive actionable intelligence from longitudinal therapeutic, diagnostic and bioinformatic data sets generated across Plus’ CNS oncology technology programs. “Plus...

Continue reading

Landstar Statement on U.S. Supreme Court Decision

JACKSONVILLE, Fla., May 19, 2026 (GLOBE NEWSWIRE) — Landstar System, Inc. (NASDAQ: LSTR), a technology-enabled, asset-light provider of integrated transportation management solutions delivering safe, specialized transportation services, today reflected on the U.S. Supreme Court’s recent decision in Montgomery v. Caribe Transport II, LLC, which addresses the scope of the Federal Aviation Administration Authorization Act’s (FAAAA) safety exception to the preemption of state law negligent selection claims. As a leading freight transportation solutions provider, Landstar has long valued safe and reliable freight transportation. In both its role as a motor carrier providing transportation through a network of approximately 8,500 trucks provided by independently owned Business Capacity Owners (BCOs) operating under Landstar’s motor carrier...

Continue reading

Mattr Reports Voting Results from Annual Meeting

TORONTO, May 19, 2026 (GLOBE NEWSWIRE) — Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced today in accordance with Toronto Stock Exchange requirements, the voting results from its Annual Meeting held May 14, 2026 in Toronto, Ontario. A total of 40,658,516 common shares were voted at the meeting representing 66.25% of the votes attached to all outstanding shares. Shareholders voted in favour of all items of business before the meeting, including the election of all director nominees as follows:Name of Nominee % of Votes For % of Votes AgainstKathleen J. Hall 96.53 3.47Alan R. Hibben 96.31 3.69Kevin L. Nugent 96.35 3.65Michael Reeves 96.35 3.65Kathy Rethy 96.54 3.46Jane Skoblo 96.51 3.49     “I appreciate the continued strong support of Mattr’s shareholders for both our strategic direction and...

Continue reading

Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy

– Alterity’s novel imaging and biomarker approach positions the Company at the forefront of clinical research in MSA –  – End-of-Phase 2 FDA Meeting on track for mid-2026 to confirm path forward for Phase 3 – MELBOURNE, Australia AND SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) —   Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that presentations related to the Company’s development program in Multiple System Atrophy (MSA) were delivered at three medical conferences showcasing Alterity’s novel imaging and biomarker approach, promising Phase 2 data, and current plans to advance ATH434 into Phase 3 clinical development. “These data continue to strengthen the evidence that ATH434...

Continue reading

Orion Announces Preliminary FY26 Revenue of $86M and Approximately $2M Adjusted EBITDA; Reiterates Expectations for Increased Growth and Profitability in FY 2027

Company to Host Q4 and Full Fiscal Year 2026 Investor Call Thursday, June 4, at 10 a.m. ET MANITOWOC, Wisc., May 19, 2026 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today announced preliminary unaudited expectations for Fiscal Year 2026 of $86 million in revenue and adjusted EBITDA of at least $2 million. The Company also reiterated expectations for Fiscal Year 2027, which began April 1, of between $95 million and $97 million in revenue and positive adjusted EBITDA. Orion said that its performance expectations continue to improve because of continuing growth in its backlog, which totaled $30 million on March 31, 2026; and ongoing increases in orders by enterprise customers;...

Continue reading

Asante Provides Financial and Operating Results for the Quarter Ended March 31, 2026

Key HighlightsCampbell Baird appointed as Chief Operating Officer and subsequent to the quarter, appointed Acting Chief Executive Officer. Q1 group gold production of 59,800 equivalent ounces at All-In-Sustaining-Cost (“AISC”) of $3,886 per equivalent ounce. Monthly average gold production in Q1 approx. 20,000 equivalent ounces, more than 50% increase on 2025 monthly average of ~13,000 equivalent ounces. Record quarterly revenue of $300.4 million and gross profit of $60.5 million. Significant investment undertaken in new mining fleet and plant upgrades in Q1. Strategic operational review of Bibiani and Chirano ongoing; focused on increasing operational reliability and driving additional production growth.VANCOUVER, British Columbia, May 19, 2026 (GLOBE NEWSWIRE) — Asante Gold Corporation (TSX.V:ASE | GSE:ASG | FRA:1A9 | OTCQX:ASGOF)...

Continue reading

Antalpha Reports First Quarter 2026 Results

SINGAPORE, May 19, 2026 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (NASDAQ: ANTA) (“Antalpha” or the “Company”) today announced its unaudited financial results for the first quarter ended March 31, 2026. “Antalpha continued to demonstrate the resilience and scalability of its platform in the first quarter, with sustained revenue growth and profitability through a more challenging market environment,” said Paul Liang, Chief Financial Officer of Antalpha. “What stood out in the first quarter of 2026 was how the two distinct sides of Antalpha’s platform worked together harmoniously. Our tokenized gold upside captured the constructive move in gold prices, and our lending portfolio, conservatively collateralized and still with no loss of principal to date, continued to reflect the risk discipline...

Continue reading

Man Group PLC : Form 8.3 – AMG Critical Materials N.V

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree AMG Advanced Metallurgical Group N.V.(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For...

Continue reading

Form 8.3 – [ANIMALCARE GROUP PLC – 18 05 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ANIMALCARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Akamai AI Brand Presence Optimizes Content and Raises Visibility in Agentic Search

Akamai AI Brand PresenceImage of the Akamai AI Brand Presence dashboard showing how users can understand which AI models are visiting a site and what content they are consuming. The dashboard also demonstrates how those AI interactions turn into real traffic and customer engagement.Optimizing brand content for AI search and agentic traffic As its own first customer, Akamai increased citations by 85% and brand presence by 364% AI bot traffic grew more than 300% year over yearCAMBRIDGE, Mass., May 19, 2026 (GLOBE NEWSWIRE) — As more people turn to AI to search and navigate the internet, Akamai (NASDAQ: AKAM) today introduced AI Brand Presence to help organizations optimize their content for AI search and traffic. AI Brand Presence enables businesses to automatically translate their website content for LLM search and AI...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.